Research advances on the prevalence and mechanism of ceftazidime-avibactam resistance

FU Qianwen, XU Jie, ZHAO Weifeng

PDF(1038 KB)
PDF(1038 KB)
Chinese Journal of Infection and Chemotherapy ›› 2022, Vol. 22 ›› Issue (4) : 509-514. DOI: 10.16718/j.1009-7708.2022.04.024
Review

Research advances on the prevalence and mechanism of ceftazidime-avibactam resistance

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 22(4): 509-514 https://doi.org/10.16718/j.1009-7708.2022.04.024

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1038 KB)

Accesses

Citation

Detail
Sections
Recommended
沪ICP备11042064-1
Copyright © Chinese Journal of Infection and Chemotherapy, All Rights Reserved.
Address：12 Wulumuqi Zhong Road Shanghai, China　
Post Code：200040
Tel: 021-52888148　
　E-mail: cjic@fudan.edu.cn 或 hscjic@fudan.edu.cn
Powered by Beijing Magtech Co. Ltd.

/

〈 〉